Plasma insulin-like growth factor 1 is associated with cognitive impairment in parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 39, Issue 5-6, 2015, Pages 251-256

  Ma, Jianfang ^a   Jiang, Qianwen ^a   Xu, Jing ^a   Sun, Qian ^a   Qiao, Yuan ^a   Chen, Wei ^a   Wu, Yiwen ^a   Wang, Ying ^a   Xiao, Qin ^a   Liu, Jun ^a   Tang, Huidong ^a   Chen, Shengdi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cognitive function; Essential tremor; Insulin like growth factor 1; Parkinson's disease

Indexed keywords

AMANTADINE; BENSERAZIDE; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SOMATOMEDIN C; TRIHEXYPHENIDYL;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; ESSENTIAL TREMOR; FEMALE; HAMILTON DEPRESSION SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNIFIED PARKINSON DISEASE RATING SCALE; BLOOD; METABOLISM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ESSENTIAL TREMOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84923117000     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000371510     Document Type: Article

References (19)

1. Godau J, Herfurth M, Kattner B, Gasser T, Berg D: Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81: 536-538.
2. Godau J, Knauel K, Weber K, Brockmann K, Maetzler W, Binder G, Berg D: Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Arch Neurol 2011; 68: 925-931.
3. Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, Wolf PA, Vasan RS, Seshadri S: Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 2014; 82: 1613-1619.
4. Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C, Vitale C, Amboni M, De Rosa A, Moccia M, Erro R, De Michele G, Santoro L, Colao A, Barone P: Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. Eur J Neurol 2014; 21: 802-807.
5. Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-Levi AC, Maison P; Huntington French Speaking Group: High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology 2010; 75: 57-63.
6. Bermejo-Pareja F: Essential tremor-a neurodegenerative disorder associated with cognitive defects Nat Rev Neurol 2011; 7: 273-282.
7. Benito-Leon J, Louis ED, Sanchez-Ferro A, Bermejo-Pareja F: Rate of cognitive decline during the premotor phase of essential tremor: a prospective study. Neurology 2013; 81: 60-66.
8. Bermejo-Pareja F, Louis ED, Benito-Leon J; Neurological Disorders in Central Spain Study Group: Risk of incident dementia in essential tremor: a population-based study. Mov Disord 2007; 22: 1573-1580.
9. Chen W, Xu ZM, Wang G, Chen SD: Non-motor symptoms of Parkinson's disease in China: a review of the literature. Parkinsonism Relat Disord 2012; 18: 446-452.
10. Chen W, Tan YY, Hu YY, Zhan WW, Wu L, Lou Y, Wang X, Zhou Y, Huang P, Gao Y, Xiao Q, Chen SD: Combination of olfactory test and substantia nigra transcranial sonography in the differential diagnosis of Parkinson's disease: a pilot study from China. Transl Neurodegener 2012; 1: 25.
11. Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P: N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 2000; 859: 286-292.
12. Miltiadous P, Stamatakis A, Stylianopoulou F: Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat. Cell Mol Neurobiol 2010; 30: 347-360.
13. Babij R, Lee M, Cortés E, Vonsattel JP, Faust PL, Louis ED: Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain 2013; 136: 3051-3061.
14. Grimaldi G, Manto M: Is essential tremor a purkinjopathy The role of the cerebellar cortex in its pathogenesis. Mov Disord 2013; 28: 1759-1761.
15. van Exel E, Eikelenboom P, Comijs H, Deeg DJ, Stek ML, Westendorp RG: Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study. Neurobiol Aging 2014; 35: 725.e7-10.
16. Mustafa A, Lannfelt L, Lilius L, Islam A, Winblad B, Adem A: Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord 1999; 10: 446-451.
17. Park IS, Oh YS, Lee KS, Yang DW, Song IU, Park JW, Kim JS: Subtype of mild cognitive impairment in elderly patients with essential tremor. Alzheimer Dis Assoc Disord 2014, Epub ahead of print.
18. Pan JJ, Lee M, Honig LS, Vonsattel JP, Faust PL, Louis ED: Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor Parkinsonism Relat Disord 2014; 20: 655-658.
19. Bermejo-Pareja F, Puertas-Martín V: Cognitive features of essential tremor: a review of the clinical aspects and possible mechanistic underpinnings. Tremor Other Hyperkinet Mov 2012; 2:http://tremorjournal.org/article/view/74.